Skin Rashes Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Rashes, including details on dermatitis, itches, creams, medication, treatment.

Volume 2 (2005), Issue 9 (September)

1. Case-control study of medical history and idiopathic pulmonary fibrosis in Japan.
   Respirology, 10(4): 504-9. [Abstract] [Full-text]
2. Erythroderma in adults: a report of 80 cases.
   Int J Dermatol, 44(9): 731-5. [Abstract] [Full-text]
3. Is the risk of lung cancer reduced among eczema patients?
   Am J Epidemiol, 162(6): 542-7. [Abstract] [Full-text]
4. Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome.
   Eur J Clin Nutr, 59(9): 1093-6. [Abstract] [Full-text]
5. Detection of IL-20 and its receptors on psoriatic skin.
   Clin Immunol, 117(1): 65-72. [Abstract] [Full-text]
6. Diaper dye dermatitis.
   Pediatrics, 116(3): e450-2. [Abstract] [Full-text]
7. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
   Pediatrics, 116(3): e334-42. [Abstract] [Full-text]
8. Molluscan and vertebrate immune responses to bird schistosomes.
   Parasite Immunol, 27(7): 247-55. [Abstract] [Full-text]
9. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice.
   Gastroenterology, 129(3): 985-94. [Abstract] [Full-text]
10. Teenage asthma after severe early childhood wheezing: An 11-year prospective follow-up.
    Pediatr Pulmonol, 40(4): 316-23. [Abstract] [Full-text]
11. Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group Canil CM, Moore MJ, Winquist E, Baetz T, Pollak M, Chi KN, Berry S, Ernst DS, Douglas L, Brundage M, Fisher B, McKenna A, Seymour L, Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
    Urol Oncol, 23(5): 378-9. [Abstract] [Full-text]
12. Failure to protect goats following vaccination with soluble proteins of Sarcoptes scabiei: evidence for a role for IgE antibody in protection.
    Vet Parasitol, 133(1): 101-9. [Abstract] [Full-text]
13. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy.
    Jpn J Clin Oncol, 35(8): 427-32. [Abstract] [Full-text]
14. Isolated vulval splitting--is this normal or pathological?
    J Obstet Gynaecol, 24(8): 899-902. [Abstract] [Full-text]
15. Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenic mouse model of atopic dermatitis.
    Microcirculation, 12(6): 455-76. [Abstract] [Full-text]
16. Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model.
    Bone Marrow Transplant. [Abstract] [Full-text]
17. Management of "refractory" skin disease in patients with lupus erythematosus.
    Best Pract Res Clin Rheumatol, 19(5): 767-84. [Abstract] [Full-text]
18. Global epidemiology of HTLV-I infection and associated diseases.
    Oncogene, 24(39): 6058-68. [Abstract] [Full-text]
19. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Int J Toxicol, 24: 51-111. [Abstract] [Full-text]
20. Amended final report of the safety assessment of t-Butyl Alcohol as used in cosmetics.
    Int J Toxicol, 24: 1-20. [Abstract] [Full-text]
21. Regulatory effect of atopic allergic reaction by Carpopeltis affinis.
    J Ethnopharmacol, 101(1): 43-8. [Abstract] [Full-text]
22. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).
    Ann Trop Med Parasitol, 99(6): 563-9. [Abstract] [Full-text]
23. Nosocomial outbreak of staphylococcal scalded skin syndrome in neonates: epidemiological investigation and control.
    J Hosp Infect, 61(2): 130-8. [Abstract] [Full-text]
24. Hyper-IgE syndrome with widespread premalign oral papillomas treated with interferon alpha2b.
    Acta Derm Venereol, 85(5): 433-5. [Abstract] [Full-text]
25. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes.
    J Neurovirol, 11(4): 384-94. [Abstract] [Full-text]
26. Without nerves, immunology remains incomplete -in vivo veritas.
    Immunology, 116(2): 145-63. [Abstract] [Full-text]
27. Alopecia in association with severe seborrhoeic dermatitis following combination antiretroviral therapy for acute retroviral syndrome.
    J Eur Acad Dermatol Venereol, 19(5): 631-3. [Abstract] [Full-text]
28. Cutaneous manifestations of familial amyloidotic polyneuropathy.
    J Eur Acad Dermatol Venereol, 19(5): 605-7. [Abstract] [Full-text]
29. The predictive value of the skin prick test weal size for the outcome of oral food challenges.
    Clin Exp Allergy, 35(9): 1220-6. [Abstract] [Full-text]
30. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis.
    Hum Mol Genet, 14(19): 2919-27. [Abstract] [Full-text]
31. Results of radiotherapy for Peyronie's disease.
    Int J Radiat Oncol Biol Phys. [Abstract] [Full-text]
32. Generation of therapeutic antibody responses against IgE in dogs, an animal species with exceptionally high plasma IgE levels.
    Vaccine. [Abstract] [Full-text]
33. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Vet Immunol Immunopathol, 108(1): 185-7. [Abstract] [Full-text]
34. Measuring atopic eczema severity visually: which variables are most important to patients?
    Arch Dermatol, 141(9): 1146-51; discussion 1151. [Abstract] [Full-text]
35. Incidence of cancer among patients with atopic dermatitis.
    Arch Dermatol, 141(9): 1123-7. [Abstract] [Full-text]
36. In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models.
    Arch Dermatol Res, 297(1): 1-9. [Abstract] [Full-text]
37. Contact sensitizers downregulate the expression of the chemokine receptors CCR6 and CXCR4 in a skin dendritic cell line.
    Arch Dermatol Res, 297(1): 43-7. [Abstract] [Full-text]
38. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score.
    Rheumatology (Oxford). [Abstract] [Full-text]
39. Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life: a multicenter, randomized trial.
    Pediatr Allergy Immunol, 16(6): 527-33. [Abstract] [Full-text]
40. The prevalence of peanut sensitization and the association to pollen sensitization in a cohort of unselected adolescents--The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS).
    Pediatr Allergy Immunol, 16(6): 501-6. [Abstract] [Full-text]
41. Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin.
    Exp Dermatol, 14(10): 752-7. [Abstract] [Full-text]
42. Changes in Immune Responses to Antigen Applied to Tape-Stripped Skin with CpG-Oligodeoxynucleotide in NC/Nga Mice.
    Pharm Res, 22(10): 1627-33. [Abstract] [Full-text]
43. Hand dermatitis: uncommon presentations.
    Clin Dermatol, 23(5): 465-9. [Abstract] [Full-text]
44. Ichthyosiform eruption associated with lamivudine in a patient with chronic hepatitis-B infection.
    Int J Clin Pract, 59(10): 1237-8. [Abstract] [Full-text]
45. The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.
    Clin Exp Immunol, 142(1): 21-30. [Abstract] [Full-text]
46. Clinical effects of stings by sponges of the genus Tedania and a review of sponge stings worldwide.
    Toxicon. [Abstract] [Full-text]
47. Cutaneous Manifestations in Italian Kidney Transplant Recipients.
    Transplant Proc, 37(6): 2527-2528. [Abstract] [Full-text]
48. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.
    Br J Dermatol, 153(4): 767-73. [Abstract] [Full-text]
49. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis.
    Br J Dermatol, 153(4): 750-7. [Abstract] [Full-text]
50. Tenascin-C is upregulated in the skin lesions of patients with atopic dermatitis.
    J Dermatol Sci, 40(1): 35-41. [Abstract] [Full-text]
51. Comparative assessment of the acute skin irritation potential of detergent formulations using a novel human 4-h patch test method.
    Food Chem Toxicol, 43(12): 1703-12. [Abstract] [Full-text]
52. Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis.
    J Invest Dermatol, 125(4): 746-52. [Abstract] [Full-text]
53. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis.
    J Invest Dermatol, 125(4): 738-45. [Abstract] [Full-text]
54. Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease.
    J Invest Dermatol, 125(4): 705-10. [Abstract] [Full-text]
55. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors.
    Vector Borne Zoonotic Dis, 5(3): 246-51. [Abstract] [Full-text]
56. Low rates of cutaneous adverse reactions to alcohol-based hand hygiene solution during prolonged use in a large teaching hospital.
    Antimicrob Agents Chemother, 49(10): 4404-5. [Abstract] [Full-text]
57. Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model.
    J Neuroimmunol. [Abstract] [Full-text]
58. Cost effectiveness of Elidel in the management of patients with atopic dermatitis in Canada.
    J Cutan Med Surg, 8(6): 405-10. [Abstract] [Full-text]
59. Legionnaires' disease associated with macular rash: two cases.
    Acta Derm Venereol, 85(4): 342-4. [Abstract] [Full-text]
60. Nickel-elicited systemic contact dermatitis from a peripheral intravenous catheter.
    Contact Dermatitis, 53(4): 222-5. [Abstract] [Full-text]
61. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders.
    J Child Adolesc Psychopharmacol, 15(4): 682-92. [Abstract] [Full-text]
62. Congenital candidiasis: a rare and unpredictable disease.
    J Perinatol, 25(10): 680-2. [Abstract] [Full-text]
63. Generalized eczema craquele as a presenting feature of systemic lymphoma: report of seven cases.
    Acta Derm Venereol, 85(4): 333-6. [Abstract] [Full-text]
64. Decreased in vitro cellular response to tetanus toxoid and tuberculin in patients using topical corticosteroids.
    Acta Derm Venereol, 85(4): 296-8. [Abstract] [Full-text]
65. Induction of a hardening phenomenon by repeated application of SLS: analysis of lipid changes in the stratum corneum.
    Acta Derm Venereol, 85(4): 290-5. [Abstract] [Full-text]
66. Generalized dermatitis due to codeine. Cross-sensitization among opium alkaloids.
    Contact Dermatitis, 53(4): 240. [Abstract] [Full-text]
67. Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences?
    Contact Dermatitis, 53(4): 219-21. [Abstract] [Full-text]
68. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia.
    Contact Dermatitis, 53(4): 214-8. [Abstract] [Full-text]
69. Occupational protein contact dermatitis from shiitake mushroom and demonstration of shiitake-specific immunoglobulin E.
    Contact Dermatitis, 53(4): 211-3. [Abstract] [Full-text]
70. The relation between the localization of foot dermatitis and the causative allergens in shoes: a 13-year retrospective study.
    Contact Dermatitis, 53(4): 201-6. [Abstract] [Full-text]
71. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
    Pediatr Dermatol, 22(5): 465-71. [Abstract] [Full-text]
72. Spectrum of phenotypic manifestations from a single point mutation of the p63 gene, including new cutaneous and immunologic findings.
    Pediatr Dermatol, 22(5): 415-9. [Abstract] [Full-text]
73. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
    J Med Chem, 48(20): 6174-7. [Abstract] [Full-text]
74. Palisaded neutrophilic granulomatous dermatitis presenting as an unusual skin manifestation in a patient with Behçet's disease.
    Scand J Rheumatol, 34(4): 324-7. [Abstract] [Full-text]
75. The management of dry skin with topical emollients--recent perspectives.
    J Dtsch Dermatol Ges, 3(10): 768-74. [Abstract] [Full-text]

© 2004-2008 Skin Rashes Research Today. All Rights Reserved.